Evidence map›Paper›PMID 30379878›Full record

ArticlePloS one2018

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.

Suresh Pallikkuth, Rajendra Pahwa, Bagavathi Kausalya, Shanmugam Saravanan, Li Pan, R Vignesh, Syed Iqbal, Sunil S Solomon, Kailapuri G Murugavel, Selvamuthu Poongulali and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Suresh PallikkuthUniversity of Miami Miller School of Medicine, Miami, Florida, United States of America.
Rajendra PahwaUniversity of Miami Miller School of Medicine, Miami, Florida, United States of America.
Bagavathi KausalyaYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Shanmugam SaravananYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Li PanUniversity of Miami Miller School of Medicine, Miami, Florida, United States of America.
R VigneshYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Syed IqbalYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Sunil S SolomonYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Kailapuri G MurugavelYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Selvamuthu PoongulaliYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Nagalingeswaran KumarasamyYRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Savita PahwaUniversity of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0002-4470-4216
YR Gaitonde Centre for AIDS Research and Education · INUniversity of Miami · USJohns Hopkins University · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GWENDOLYN Barbara SCOTT · 2007 to 2026
$33.8M
Immune Activation in Virologically Suppressed Indian HIV-infected PatientsR21AI106373 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2013 to 2014
$420k
NIAID NIH HHS P30 AI073961NIAID NIH HHS R21 AI106373
6 · The paper itself

Abstract

Recent findings point to a role of Checkpoint Inhibitor (CPI) receptors at the tissue level in immune homeostasis. Here we investigated the role of CPI molecules on immune cells in relation to cardiac function. Participants recruited in Chennai, India consisted of HIV+ ART naive viremic (Gp1 n = 102), HIV+ on ART, virologically suppressed (Gp2, n = 172) and HIV negative healthy controls (Gp3, n = 64). A cross-sectional analysis of cardiac function, arterial resistance and immunologic assessment of CPI expressing T cells was performed. Data indicate that ART naive exhibited cardiac function impairment and greater arterial stiffness than the other groups. Frequencies of CD4+ T cells expressing LAG-3 and PD1 were higher in ART naïve while TIGIT and TIM3 were similar among the patient groups. LAG-3+, PD1+ and dual LAG-3+PD1+ CD4 T cells were inversely correlated with cardiac function and arterial elasticity and directly with arterial stiffness in ART naïve participants and with arterial elasticity in virally suppressed group on ART. We conclude that HIV induced upregulation of LAG-3 singly or in combination with PD1 in immune cells may regulate cardiac health and warrant mechanistic investigations. The implications of these findings have bearing for the potential utility of anti-LAG-3 immunotherapy for cardiac dysfunction in chronic HIV infection.

Indexed as

AdultAntigens, CDAnti-HIV AgentsCardiovascular DiseasesCD4-Positive T-LymphocytesFemaleGene Expression RegulationHeartHIV InfectionsHumansLymphocyte Activation Gene 3 ProteinMaleMiddle AgedMorbidityProgrammed Cell Death 1 ReceptorVascular StiffnessAntigens, CDAnti-HIV AgentsLag3 protein, humanLymphocyte Activation Gene 3 ProteinPDCD1 protein, humanProgrammed Cell Death 1 Receptor

Identifiers

PMID30379878
PMCPMC6209232
OpenAlexW2899158625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.